Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (UT2 -Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) applications from small business concerns (SBCs) that propose the development of therapeutic agents for disorders that fall under the mission of NIAAA.
An identified candidate, having sufficient bioactivity,
stability, manufacturability, bioavailability, in vivo efficacy and/or target engagement, and other favorable properties that are consistent with the desired clinical application, is required prior to application.
The FOA supports Investigational New Drug (IND)-enabling studies for the therapeutic candidate.
At the end of the funding period, a successful project should have, at a minimum, an IND application submitted to the U. S. Food and Drug Administration (FDA).
The program supports early-phase clinical trials, although these are not required.
An identified candidate, having sufficient bioactivity,
stability, manufacturability, bioavailability, in vivo efficacy and/or target engagement, and other favorable properties that are consistent with the desired clinical application, is required prior to application.
The FOA supports Investigational New Drug (IND)-enabling studies for the therapeutic candidate.
At the end of the funding period, a successful project should have, at a minimum, an IND application submitted to the U. S. Food and Drug Administration (FDA).
The program supports early-phase clinical trials, although these are not required.
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: $100,000
Office: National Institutes of Health
Estimated Funding: $100,000
Who's Eligible
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PAR-18-580.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/pa-files/PAR-18-580.html
Contact:
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
Date Posted:
2018-01-12
Application Due Date:
Archive Date:
2021-01-09
Social Entrepreneurship
Spotlight
Calgary Social Enterprise Offers High-Tech Services by People with Autism
Meticulon, a project of Autism Calgary Association in partnership with the federal government and the Sinneave Family Foundation, operates as a social enterprise that renders high-tech services provided by people with autism, leveraging their natural abilities at requiring attention to detail, repetition, and sequencing.
Learn How to Identify and Avoid Grant Scams
